![Keith Fandrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/09/2026
Dr. Keith R.
Fandrick is a Chief Operating Officer at IRulya Therapeutics, Inc. Dr. Fandrick was previously employed as a Chief Operating Officer by OrphAI Therapeutics, Inc. He received his undergraduate degree from the University of California, a graduate degree from Harvard University, an MBA from Kenan-Flagler Business School and a doctorate degree from Harvard University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/10/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Director de Operaciones | 08/10/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
AI Therapeutics, Inc.
 AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenan-Flagler Business School
 Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
